Determinants of outcome in patients eligible for thrombolysis for ischemic stroke

References

• AdamsHPJrBendixenBHKappelleLJClassification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke TreatmentStroke19932435417678184
   PubMed Web of Science ®Google Scholar
• AlbersGWBatesVEClarkWMIntravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) studyJAMA200028311455010703776
   PubMed Web of Science ®Google Scholar
• ArnoldMNedeltchevKSturzeneggerMThrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literatureArch Neurol2002595495311939889
   PubMed Web of Science ®Google Scholar
• BrunoALevineSRFrankelMRNINDS rt-PA Stroke Study GroupAdmission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialNeurology2002596697412221155
   PubMed Web of Science ®Google Scholar
• ClarkWMWissmanSAlbersGWRecombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Non-interventional Therapy in Ischemic StrokeJAMA199928220192610591384
   PubMed Web of Science ®Google Scholar
• DemchukAMTanneDHillMDPredictors of good outcome after intravenous t-PA for acute ischemic strokeNeurology2001574748011502916
   PubMed Web of Science ®Google Scholar
• Del ZoppoGPPoeckKPessinAJRecombinant intravenous plasminogen activitor in acute thrombotic and embolic strokeAnn Neurol19923278861642475
   PubMed Web of Science ®Google Scholar
• European Stroke Initiative recommendations for stroke managementEuropean Stroke Council, European Neurological Society and European Federation of Neurological SocietiesCerebrovasc Dis2000103355110971019
   PubMedGoogle Scholar
• European Stroke Initiative recommendations for stroke management-updateCerebrovasc Dis2003163113714584488
   PubMed Web of Science ®Google Scholar
• GoldsteinLBBertelsCDavisJNInterrater reliability of the NIH Stroke ScaleArch Neurol19894666022730378
   PubMed Web of Science ®Google Scholar
• GrondMStenzelCSchmullingSEarly intravenous thrombolysis for acute ischemic stroke in a community-based approachStroke199829154499707190
   PubMed Web of Science ®Google Scholar
• HackeWKasteMFieschiCIntravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke StudyJAMA19952741017257563451
   PubMed Web of Science ®Google Scholar
• HackeWSchwabSHornMMalignant middle cerebral artery territory infarctionArch Neurol1996533093158929152
   PubMed Web of Science ®Google Scholar
• HackeWKasteMFieschiCRandomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II)Lancet19983521245519788453
   PubMed Web of Science ®Google Scholar
• HackeWBrottTCaplanLThrombolysis in acute ischemic stroke: controlled trials and clinical experienceNeurology199953S31410532643
   PubMed Web of Science ®Google Scholar
• HackeWDonnanGFieschiCAssociation of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsLancet20043637687415016487
   PubMed Web of Science ®Google Scholar
• HenonHGodefroyOLeysDEarly predictors of death after acute cerebral ischemic eventsStroke19952639287886712
   PubMed Web of Science ®Google Scholar
• HeuschmannPUKolominsky-RabasPLRoetherJPredictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapyJAMA20042921831815494580
   PubMed Web of Science ®Google Scholar
• HillMDBuchanAMCanadian Alteplase for Stroke Effectiveness Study (CASES) InvestigatorsThrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness StudyCMAJ200517213071215883405
   PubMed Web of Science ®Google Scholar
• LeysDPruvoJPPetitHMaladie d’Alzheimer, analyse statistique des resultats du scanner XRev Neurol198914513492727536
   PubMedGoogle Scholar
• LinfanteILlinasRHSelimMClinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusion after intravenous tissue plasminogen activatorStroke20023320667112154264
   PubMed Web of Science ®Google Scholar
• MoriEYonedaYTabuchiMIntravenous recombinant tissue plasminogen activator in acute carotid artery territory strokeNeurology1992976821579252
   PubMed Web of Science ®Google Scholar
• MouradianMSSenthilselvanAJicklingGIntravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patientsJ Neurol Neurosurg Psychiatry2005761234716107357
   PubMed Web of Science ®Google Scholar
• PexmanJHBarberPAHillMDUse of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute strokeAJNR Am J Neuroradiol20012215344211559501
   PubMed Web of Science ®Google Scholar
• RudolfJNevelingMGrondMStroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis?Eur J Neurol1999651510209350
   PubMed Web of Science ®Google Scholar
• SartiCStegmayrBTolonenHAre changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA ProjectStroke20033418334012855832
   PubMed Web of Science ®Google Scholar
• SaposnikGYoungBSilverBLack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcomeJAMA200429218394415494581
   PubMed Web of Science ®Google Scholar
• SchellingerPDFiebachJBMohrAThrombolytic therapy for ischemic stroke – a review. Part I – Intravenous thrombolysisCrit Care Med20012918121811546993
   PubMed Web of Science ®Google Scholar
• SylajaPNCoteRBuchanAMCanadian Alteplase for Stroke Effectiveness Study (CASES) InvestigatorsThrombolysis in patients older than 80 years with acute ischemic stroke: Canadian Alteplase for Stroke Effectiveness StudyJ Neurol Neurosurg Psychiatry200677826916505004
   PubMed Web of Science ®Google Scholar
• TanneDGormaMJBatesVEIntravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older. The t-PA Stroke Survey ExperienceStroke200031370510657408
   PubMed Web of Science ®Google Scholar
• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study GroupTissue plasminogen activator for acute ischemic strokeN Engl J Med1995333158177477192
   PubMed Web of Science ®Google Scholar
• TrouillasPNighoghossianNDerexLThrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factorsStroke1998292529409836764
   PubMed Web of Science ®Google Scholar
• van SwietenJCKoudstaalPJVisserMCInterobserver agreement for the assessment of handicap in stroke patientsStroke19881960473363593
   PubMed Web of Science ®Google Scholar
• WeimarCZieglerAKonigIRPredicting functional outcome and survival after acute ischemic strokeJ Neurol20022498889512140674
   PubMed Web of Science ®Google Scholar
• WHO Guidelines SubcommitteeWorld Health Organization - International Society of Hypertension Guidelines for the Management of HypertensionJ Hypertens1999171518310067786
   PubMed Web of Science ®Google Scholar